ArticleFrontiers in endocrinology2026
Thyroid diseases and risk of peripheral neuropathy in a large population-based cohort: evidence from the UK Biobank.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thyroid dysfunction has been linked to several neurological disorders, but the association between thyroid diseases and peripheral neuropathy remains insufficiently explored in large population-based cohorts. We aim to investigate the association between thyroid diseases and peripheral neuropathy. Methods: We analyzed 498,417 complete-case participants from the UK Biobank with linked hospital diagnosis records. Thyroid diseases were defined using ICD-10 codes, including hypothyroidism, hyperthyroidism, and thyroid cancer. Peripheral neuropathy was identified using ICD-10 codes G60-G64. Multivariable logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs). Results: Peripheral neuropathy was identified in 6,341 participants. In the fully adjusted model including demographic, lifestyle, socioeconomic, and clinical covariates, hypothyroidism was significantly associated with peripheral neuropathy (OR 1.29, 95% CI 1.18-1.40), and hyperthyroidism showed a weaker but statistically significant association (OR 1.22, 95% CI 1.01-1.45). Thyroid cancer was not significantly associated with peripheral neuropathy (OR 1.16, 95% CI 0.66-1.89). In sensitivity analyses excluding participants with diabetes, hypothyroidism remained associated with peripheral neuropathy, whereas the association for hyperthyroidism was attenuated. Discussion: Clinically diagnosed hypothyroidism and hyperthyroidism were associated with higher odds of peripheral neuropathy in this UK Biobank-based analysis. These findings should be interpreted as associations rather than causal relationships, given the observational design and lack of thyroid hormone levels, disease severity, and treatment information.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.